SOCS1 and systemic lupus erythematosus: Furthermore, miR-155 inhibition was demonstrated to alleviate SLE symptoms by preventing regulatory T-cell (Tregs) impairment through the suppressor of cytokine signaling 1 protein in an in vivo mouse model [41].